ArticleCancer medicine2021

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort.

Katsuhiro Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.